Tag: invasive candidiasis
Mundipharma’s rezafungin cleared by MHRA for invasive candidiasis in Great Britain
In a significant advancement for antifungal therapy, Napp Pharmaceuticals Limited, a key player within the international network of Mundipharma independent associated companies, has announced the ... Read More
Cidara Therapeutics’ REZZAYO bags UK and EU approvals in invasive candidiasis
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with the United Kingdom (U.K.) Medicines and Healthcare ... Read More